Latest News

Axon commands a premium valuation despite slower profit margins, while Monday.com trades at a discount with stronger cash generation, a key divergence for long-term investors.

AI is not the only technology-driven growth story worth watching. This fintech is expanding across banking, lending, investing, and digital payments.

The red-hot healthcare stock may soon have another catalyst that drives its value even higher.

JetBlue reported big losses last week -- but also big hope for a turnaround in earnings in 2028.

Compares the Roundhill GLP-1 & Weight Loss ETF (OZEM) and the newer REX Peptide ETF (PEPT), examining holdings, fees, and overlap as GLP-1 drug demand from Eli Lilly and Novo Nordisk continues to grow.

AbbVie, J&J, and Medtronic remain reliable dividend plays in a rough market.

The company’s comeback story is just getting started.

Record APU revenue and margins drive profitability surge amid aerospace aftermarket strength.

After a notable plunge, the cloud and AI specialist is rebounding.

GameStop boasts an 11.5% net margin and $597M in free cash flow, while Advance Auto Parts struggles with negative cash generation and heavy debt.

2027 is coming, and these four stocks could be smart buys now.

On Nov. 2, 2026, crude plummeted roughly 7% on Middle East ceasefire prospects, sparking broad risk-on sentiment across major indexes.

Marvell said it has agreed to combine with Lumentum (NASDAQ:LITE), positioning the proposed transaction as a move to build a larger provider of optical connectivity technology for artificial-intelligence infrastructure. Marvell Chairman and CEO Matt Murphy said the combination would bring together

The rumor is true: SpaceX is building a cellphone provider.

Alphabet is investing hundreds of billions of dollars in AI. But can those investments generate enough returns to justify the spending?

Panama City, Guanacaste in Costa Rica and Lagos, Portugal top one investor's list for rental income and long-term growth, with Portuguese mortgages from 2.6%.

IDEXX raised its 2026 earnings forecast, but it also trimmed its margin outlook. Here’s what is really behind the raise, and why testing demand isn’t the reason.

Oracle stock has lost over $60 billion in market value since its investor day after a $20 billion stock and bond sale. Here's why the sell-off could be an opportunity.

HPC revenue surged as Barber Lake lease doubled to 20 years with $9.1B contracted value.

RevPAR surged 6.5% as global travel demand remained robust.

Oncology volume surged 32% while data licensing bookings topped $550 million year-to-date.

AUVELITY revenue surged 52% as Alzheimer's disease agitation gains traction.

VYJUVEK revenue surged 30% YoY to $127.3 million amid $400 million buyback authorization.

IBM trades at a lower valuation but carries heavier debt, while Synopsys boasts stronger margins and a cleaner balance sheet.

GE Aerospace's $7.3B free cash flow contrasts sharply with SpaceX's $14B cash burn, yet one trades at a 19x valuation premium.